期刊文献+

大肠癌的基因治疗 被引量:8

下载PDF
导出
摘要 大肠癌(colorectal cancer,CRC)是威胁人类生存的恶性肿瘤之一.由于大肠癌比较适于基因治疗,因此他是目前大肠癌研究的热点问题之一.基因治疗主要包括自杀基因治疗, 与原癌基因和抑癌基因有关的基因治疗,免疫基因治疗和联合治疗等.有些研究已经进入临床试验阶段.本文介绍了大肠癌的基因治疗研究进展和存在的问题,为今后的医疗科研工作提供新的思路.
出处 《世界华人消化杂志》 CAS 2004年第6期1451-1454,共4页 World Chinese Journal of Digestology
  • 相关文献

参考文献43

  • 1Kerr D.Clinical development of gene therapy for colorectal cancer.Nat Rev Cancer 2003;3:615-622.
  • 2Denny WA, Wilson WR. The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and genedirected enzyme-prodrug therapies. J Pharm Pharmacol 1998;50:387-394.
  • 3Friedlos F, Court S, Ford M, Denny WA, Springer C. Genedirected enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase. Gene Ther 1998;5:105-112.
  • 4Friedlos F, Denny WA, Palmer BD, Springer CJ. Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy. J Med Chem 1997;40:1270-1275.
  • 5Clark AJ, Iwobi M, Cui W, Crompton M, Harold G, Hobbs S,Kamalati T, Knox R, Neil C, Yull F, Gusterson B. Selective cell ablation in transgenic mice expression E.coli nitroreductase.Gene Ther 1997;4:101-110.
  • 6Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-5281.
  • 7Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy.Hum Gene Ther 1993;4:725-731.
  • 8McMasters RA, Saylors RL, Jones KE, Hendrix ME, Moyer MP, Drake RR. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation. Hum Gene Ther 1998;9:2253-2261.
  • 9Kuriyama S, Kikukawa M, Masui K, Okuda H, Nakatani T,Sakamoto T, Yoshiji H, Fukui H, Ikenaka K, Mullen CA, Tsujii T. Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice. Int J Cancer 1999;81:592-597.
  • 10Barnes LD, Garrison PN, Siprashvili Z, Guranowski A,Robinson AK, Ingram SW, Croce CM, Ohta M, Huebner K.Fhit, a putative tumor suppressor in humans, is a dinucleoside 5', 5"'-P1,P3-triphosphate hydrolase. Biochemistry 1996;35:11529-11535.

同被引文献129

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部